On behalf of all of us at Surface, we would like to thank our colleagues at @ASCO for the opportunity to present new data from our ongoing Phase 1 study of SRF388. We are honored to work in this transformative field. View the poster here: https://t.co/C56DezXMsU #ASCO21 https://t.co/I8m06aB1lM